Spire Healthcare Group PLC Director/PDMR Shareholding (3329D)
October 08 2018 - 9:54AM
UK Regulatory
TIDMSPI
RNS Number : 3329D
Spire Healthcare Group PLC
08 October 2018
8 October 2018
Spire Healthcare Group plc
Grant of 2018 Long Term Incentive Plan awards
Spire Healthcare Group plc (the "Company") announces that, on 8
October 2018, a performance share award (the "Award") was granted
over the Company's ordinary shares in the form of nil cost options
to the following Executive Director in the Company, under the rules
of the Spire Healthcare Group plc Long Term Incentive Plan.
Name Maximum number of shares under Award
Jitesh Sodha 415,381
The number of shares set out above is the maximum number which
may vest under the Award following the cessation of the performance
period. The actual number of shares which vest will depend on the
extent to which the following performance conditions have been
satisfied.
The performance conditions applicable to the Award will be based
as follows:
-- 35% on relative total shareholder return (TSR) performance;
-- 35% on adjusted earnings per share (EPS) performance; and
-- 30% on two Operational Excellence measures.
Furher details of these performance conditions were disclosed in
the 2017 Directors' Remuneration Report which was published in
April.
The share price used to determine the number of shares under the
Award was GBP1.4264 being the average of the middle market
quotation over the last five dealing days ending on 5 October
2018.
The transaction place is London.
Name of contact and telephone number for queries:
Philip Davies 020 7427 9092
Deputy Company Secretary
The following disclosure is made in accordance with Article 19
of the EU Market Abuse Regulation 596/2014.
a) Name Jitesh Sodha
------------------------------------- --------------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------
a) Position/status Chief Financial Officer and Executive Director
------------------------------------- --------------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- --------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------------
a) Name Spire Healthcare Group plc
------------------------------------- --------------------------------------------------
b) LEI 213800IBJPW3SE2RA350
------------------------------------- --------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type GB00BNLPYF73
of instrument
Identification
code
------------------------------------- --------------------------------------------------
b) Nature of the Grant of performance share awards under
transaction the Company's Long Term Incentive Plan
------------------------------------- --------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
------------------------------------- ----------------------- -------------------------
Nil 415,381
------------------------------------------------------------------ -------------------------
d) Aggregated information As above
- Aggregated volume
- Price
------------------------------------- --------------------------------------------------
e) Date of the transaction 2018-10-08
------------------------------------- --------------------------------------------------
f) Place of the transaction XLON
------------------------------------- --------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBSBDGXUGBGII
(END) Dow Jones Newswires
October 08, 2018 10:54 ET (14:54 GMT)
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From Apr 2024 to May 2024
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From May 2023 to May 2024